Azitra (AZTR) Change in Cash (2022 - 2026)
Azitra's (AZTR) quarterly Change in Cash came in at $8.0 million in Q1 2026, up 692.2% YoY from $1.0 million in Q1 2025, and up 1098.27% on a QoQ basis from $666205.0 in Q4 2025.
Azitra (AZTR) Change in Cash (2022 - 2026) Analysis & Trends
Azitra (AZTR) has 5 years of Change in Cash data on file, last reported at $8.0 million in Q1 2026.
- Quarterly Change in Cash rose 692.2% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (up 3229.71% YoY) and the FY2025 annual result came in at -$2.5 million, down 190.14% from the prior year.
- Change in Cash grew to $8.0 million in Q1 2026, from $666205.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $8.0 million in Q1 2026 to a low of -$2.7 million in Q4 2024.
- A 5-year average of $419977.9 and a median of -$1.3 million in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2025 — Change in Cash plunged 211.85% — and 2026, when it soared 692.2%.
- Tracing AZTR's Change in Cash over 5 years: stood at -$2.4 million in 2022, then declined by 6.49% to -$2.6 million in 2023, then slipped by 3.88% to -$2.7 million in 2024, then soared by 124.62% to $666205.0 in 2025, then jumped by 1098.27% to $8.0 million in 2026.
- The last three Change in Cash figures came in at $8.0 million (Q1 2026), $666205.0 (Q4 2025), and $356148.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Azitra | 2.53 Mn | 2.53 Mn | - | -3.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.32 Mn |
| Mar 31, 2026 | 7.98 Mn |
| Dec 31, 2025 | 666,205.00 |
| Sep 30, 2025 | 356,148.00 |
| Jun 30, 2025 | -2.16 Mn |
| Mar 31, 2025 | -1.35 Mn |
| Dec 31, 2024 | -2.71 Mn |
| Sep 30, 2024 | 6.46 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | -2.60 Mn |
| Sep 30, 2023 | -1.89 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | -1.66 Mn |
| Dec 31, 2022 | -2.45 Mn |
| Sep 30, 2022 | 2.19 Mn |